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SUMMARY 
A 53-year-old man was admitted to our internal medicine unit with intestinal obstruction and signs 
of systemic inflammatory disease. Clinical history was unremarkable until a few months earlier, 
when he began suffering from Achilles tendonitis. Diagnostic procedures, including laparotomy, 
revealed diffuse thickening of the peritoneum resembling sclerosing encapsulating peritonitis. 
Biopsies showed reactive fibrosis. No known secondary causes were found and surgery was 
technically not feasible. Clinical conditions worsened daily until, on the basis of the overall 
spectrum of clinical and radiological findings, Whipple’s disease was hypothesised and specific 
therapy administered, with prompt clinical improvement. Complete disappearance of the cocoon 
was demonstrated at 1 year clinical/ultrasound/computed tomography follow-up. 
 
BACKGROUND 
Sclerosing encapsulating peritonitis is a rare cause of small bowel obstruction and can be classified 
as primary or secondary, the latter usually linked to chronic peritoneal dialysis. The primary form, 
known as abdominal cocoon, was first described by Foo et al in 1978.1 It is characterised by a thick, 
fibrotic, cocoon-like membrane, partially or totally encasing the small bowel. Clinically, it presents 
with recurrent episodes of acute or sub-acute small bowel obstruction, weight loss, nausea and 
anorexia, and occasionally with a palpable abdominal mass.2 Diagnosis is often made during 
laparotomy for intestinal obstruction and frequently surgical treatment is mandatory, comprising 
adhesiolysis and small bowel intubation.3 Abdominal cocoon is mainly reported in young adolescent 
females from tropical countries, and its aetiology is still challenging. Some authors believe that 
subclinical viral peritonitis, gynaecological infections or retrograde menstruation could play a role.4 
Some reports describe an association between abdominal cocoon and infectious disease, in 
particular tuberculosis.4 However, this is the first case of primary sclerosing peritonitis associated 
with Whipple’s disease. The complete recovery after treatment for Tropheryma whipplei strongly 
supports this contention. 
CASE PRESENTATION 
In April 2005 a 53-year-old man was admitted to our internal medicine unit because of intestinal 
obstruction associated with fever, epigastric pain, nausea and biliary vomit. He was in good health 
until January 2005 when he began to suffer from bilateral Achilles tendonitis. Laboratory findings 
showed normocytic anaemia and increased values of inflammatory markers (fibrinogen 654 mg/dl, 
erythrocyte sedimentation rate (ESR) 78 ml/h, C reactive protein (CRP) 134 mg/l). 
INVESTIGATIONS 
The patient’s history is extremely complex. For the sake of clarity, the clinical course is described in 
three steps. 
Initial admission and first investigations. Abdominal x ray showed proximal small bowel air–
fluid levels due to intestinal obstruction. Abdominal computed tomography (CT) scan revealed 
ascites and deformation of the periduodenal tract of the bowel and of the Treitz ligament associated 
with thickening of the mesentery and peritoneum. Paracentesis documented exudative ascites 
together with inflammatory and epitheliomorphic cells. Laparotomy showed conspicuous ascites (6 
litres), thickened mesentery and peritoneum as well as dense interbowel adhesions, creases, and 
pseudonodules. Biopsy specimen examination revealed nodular fibrosis (neoplastic-like) of the 
mesentery and hyperplastic lymphadenitis without atypical cells. Positron emission tomography 
(PET) total body scan showed no pathologic areas and the re-evaluation of the biopsy samples 
confirmed the absence of neoplastic cells. A few days later, paracentesis was repeated and increased 
values of Ca-125 (790 U/ml) were detected. Cultural examinations of ascites were negative for 
common bacterial agents and Koch Bacillus (KB), similarly to CRP and microscopic examination. 
Conversely, a Mantoux intradermic reaction and quantiferon-gold were positive. The patient then 
underwent an oesophagogastroduodenoscopy (OGD) that showed no alterations of the mucosa; 
therefore biopsy was not performed. A chest x ray showed a right infiltrate compatible with active 
pneumonia. Antibiotic treatment with ceftriaxone was empirically given for 3 weeks 
The infectious diseases unit and the "tuberculosis hypothesis". At that time, hypothesising 
intestinal tuberculosis, the patient was transferred to the infectious diseases unit (IDU) where he was 
administered specific therapy for KB comprising in four drugs (rifampin, isoniazide, ethambuthol, 
pyrazinamide). Two weeks later bowel function resumed, ascites decreased, and the patient started 
eating again. He was therefore discharged with the presumed diagnosis of "tubercular peritonitis" 
and followed-up by infectious disease specialists. After 2 months, treatment was reduced to two 
drugs (isoniazide and rifampin). One month later the patient started to feel abdominal tension. 
Ultrasound showed a relapse of peritoneal effusion. He was re-admitted to the IDU. An abdominal 
and thoracic CT scan showed limited bilateral pleural effusion, multiple lymphadenopathies of the 
mesentery, thickening of the peritoneum and fluid levels (fig 1).5–8 A new laparotomy confirmed 
diffused and increased thickening of the peritoneum resembling abdominal cocoon. The biopsy 
documented reactive fibrosis, without atypical cells. 
  
Figure 1 Axial contrast enhanced computed tomography (CT) images, acquired in September 2006 
(pre-therapy) show diffuse ascites, clustered loops of small bowel (B), retroperitoneal low 
attenuation lymphadenopathies (B), and diffuse thickening of the mesentery, omentum, and parietal 
peritoneum (A, B, C). 
From tuberculosis to Whipple’s disease. Bearing in mind the patient’s clinical course, as well as 
the results of the latest examinations, Whipple’s disease was hypothesised. Treatment with 
ceftriaxone and cotrimoxazole was started. Two weeks later, peristalsis slowly normalised together 
with bowel function, and ascites noticeably decreased. The patient regained appetite and started 
eating normally. 
DIFFERENTIAL DIAGNOSIS 
Mechanical causes of intestinal obstruction (intussusception, hernia torsion, volvulus), peritoneal 
carcinosis, mesothelioma of the peritoneum, sarcoidosis, intestinal tuberculosis, atypical infectious 
diseases. 
TREATMENT 
Ceftriaxone and cotrimoxazole for 12 months. 
OUTCOME AND FOLLOW-UP 
At the time of discharge, bowel function was regular, blood count was almost normal and the 
patient had gained 6 kg. At 3 and 6 months follow-up, the patient was healthy, with no clinical or 
ultrasound signs of ascites. An abdominal CT scan performed after 12 months confirmed the 
absence of ascites and peritoneum thickening (fig 2). 
 
 
Figure 2 Axial contrast enhanced CT images, acquired after 9 months of treatment with 
cotrimoxazole and ceftriaxone, show complete resolution of ascites and thickening of the 
peritoneum.  
DISCUSSION 
Whipple’s disease is a rare systemic infection that may involve any major system. Although 
potentially fatal, it dramatically responds to antibiotic treatment.9 To the best of our knowledge, in 
the indexed literature Whipple’s disease complicated by peritoneal involvement is outlined in only 
one review, but abdominal cocoon is not mentioned.10 Our diagnosis lacks histologic confirmation; 
however, it fulfils the criteria based on the surprising clinical response to ceftriaxone and 
cotrimoxazole confirmed by radiological findings. 
Our patient never underwent peritoneal dialysis nor was treated with practolol. Previous symptoms 
that could indicate recurrent peritonitis11 were absent. The biopsy of the cocoon was performed 
twice and on both occasions showed reactive fibrosis excluding carcinosis and mesothelioma of the 
peritoneum. Sclerosing encapsulating peritonitis has sometimes been associated with intestinal 
tuberculosis or sarcoidosis.12 In our case report although quantiferon-gold and Mantoux tests were 
positive (indicating a previous contact with KB), no evidence of active tuberculosis was detectable 
in the bioptic specimen. Moreover, despite treatment for KB, ascites and intestinal obstruction 
relapsed. The recurrence of the disease compelled us to reconsider the whole history, the clinical 
course, the radiological findings, and the response to our therapeutic strategy. The CT findings 
drove the diagnosis, in particular the finding of the cluster of jejunal loops in a sack-like membrane 
with diffuse thickening of the mesentery, omentum, and parietal peritoneum, in combination with 
low attenuation mesenteric/retroperitoneal adenopathies (fig 1). These features are, in fact, 
suggestive mainly of either mycobacterial infection or Whipple’s disease.10 However, the 
association with articular disease (Achilles tendonitis, in this case) and the clinical relapse of 
intestinal obstruction during tuberculosis treatment would favour the second hypothesis. Moreover, 
in our opinion, the first clinical improvement was due to ceftriaxone (administered for pneumonia) 
that is known to be effective against Tropheryma whipplei, and not to tuberculosis treatment. 
Therapy with cotrimoxazole and ceftriaxone was attempted with a prompt clinical response. A new 
OGD with biopsy of the duodenum was performed and the specimen was sent to the European 
Centre for Whipple’s disease: no foamy period acid-Schiff (PAS) positive macrophages were found 
and CRP for T whipplei was negative. However, this may occur shortly after initiation of antibiotic 
treatment13; thus we assumed that cotrimoxazole and ceftriaxone may have influenced the results. 
We are not able to demonstrate how T whipplei may have induced peritoneal sclerosis. 
Nevertheless, as underlined in a recent review, Whipple’s disease can be defined as a macrophage 
disease, and it is well known how these cells play a pivotal role in the cytokine network and 
production of TGF-β.14 This is speculative and further studies are needed to prove this relation. In 
our opinion, considering the prompt response to specific therapy in the absence of any other cause 
of abdominal cocoon, and considering also the CT findings and some of the clinical features, 
Whipple’s disease complicated by abdominal cocoon is a reasonable diagnostic hypothesis. Indeed, 
the most important follow-up criterion for successful treatment in patients with Whipple’s disease is 
known to be the improvement of clinical symptoms, which should occur in the first 2 weeks after 
initiation of treatment.13 
LEARNING POINTS 
• In the case of intestinal obstruction with no apparent cause, Whipple’s disease should be 
considered a possible diagnosis. 
• Abdominal cocoon can probably be caused by Tropheryma whipplei. 
• Specific therapy can lead to complete recovery even at an advanced stage of the disease. 
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